Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/109120
Kind Code:
A1
Abstract:
TYK2 inhibitors, pharmaceutical compositions of these compounds,methods of preparation and the use thereof against various TYK2-mediated diseases and disorders.

Inventors:
WAN ZHAOKUI (CN)
LI XIAODONG (CN)
VAZQUEZ MICHAEL LAWRENCE (CN)
Application Number:
PCT/CN2022/106876
Publication Date:
June 22, 2023
Filing Date:
July 20, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LYNK PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D403/12; A61K31/501; A61P1/00; A61P19/02; A61P29/00; A61P37/06; C07D401/12; C07D401/14; C07D405/12; C07D409/14; C07D417/14
Domestic Patent References:
WO2020156311A12020-08-06
WO2014074661A12014-05-15
WO2014074660A12014-05-15
WO2015069310A12015-05-14
WO2007027238A22007-03-08
WO2021202652A12021-10-07
WO2013104573A12013-07-18
WO2013171690A12013-11-21
Foreign References:
CN111484480A2020-08-04
CN113563309A2021-10-29
CN1625400A2005-06-08
CN102066339A2011-05-18
CN102066340A2011-05-18
CN104470363A2015-03-25
JP2014198693A2014-10-23
CN101506177A2009-08-12
CN103492370A2014-01-01
CN113968846A2022-01-25
US20220002267A12022-01-06
Other References:
VARAļ¼ŒBRANDON A. ET AL.: "Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds", ACS MEDICINAL CHEMISTRY LETTERS, vol. 12, 19 March 2021 (2021-03-19), pages 653 - 661, XP055938211, DOI: 10.1021/acsmedchemlett.1c00096
DATABASE Registry CAS; 6 July 2021 (2021-07-06), ANONYMOUS : "1,2,4-Triazine-6-carboxa mide, 5-[(1-ethyl-1Hindazol-5-yl)amino]- 3-[(3S)-3- piperidinylamino]-", XP093072980, retrieved from STN Database accession no. 2649656-47-1
Attorney, Agent or Firm:
LIFANG & PARTNERS (CN)
Download PDF: